Release date: 2016-08-24
Mr. Zhang, a 38-year-old executive from a foreign company, suddenly had a right limb hemiplegia after a night of socializing. The left side of the mouth was drooping, he could not walk, and his activities were difficult. He was rushed to the Rocket General Hospital. After examination, he was diagnosed with intracranial artery stenosis and induced transient ischemic attack (the degree of stenosis has reached 80%). If not treated in time, the artery may be acutely occluded, causing irreversibility. Sexual cerebral infarction leads to lifelong disability. Professor Jiang Weijian, an internationally renowned neuro-interventional expert and vice president of the Rocket General Hospital, carefully analyzed the condition of Mr. Zhang and implemented the “intracranial Apollo stenting procedure†for the first time. All the symptoms before Mr. Zhang’s onset disappeared. Restored the lives of normal people.
Difficult treatment of intracranial artery stenosis in China
In China, intracranial artery stenosis has long plagued experts in the field of neurological intervention. The disease has five distinctive features. First, in China, the prevalence rate of people over 40 years old is 6.9%. Second, intracranial artery stenosis is the most important cause of ischemic stroke in Chinese, accounting for 33%; The pathogenic mechanism is arterial-arterial embolism with impaired clearance; fourth, the prognosis is poor, the stroke rate is 17% in the first year, and the mortality rate is 11%; fifth, heparin treatment fails to improve the prognosis.
For the situation shown in such a set of data, Jiang Weijian gave the word - severe. The difficulty in effectively controlling such a severe reality is that intracranial artery stenosis stenting is difficult and risky.
First, the anatomical structure of the intracranial artery is significantly different from the extracranial artery: the vessel wall is weak and rich in perforating vessels; the stroke is long and distorted; floating in the cerebrospinal fluid, relying on small blood vessels to fix. Second, the stent system is difficult to deliver or susceptible to vascular damage. Third, the surgery lacks a dedicated stent.
It can be seen that the treatment of intracranial cerebral artery stenosis has become an important aspect of the prevention and treatment of ischemic cerebrovascular disease. The traditional drug treatment effect is not satisfactory. In recent years, stenting has been used internationally to treat intracranial artery stenosis. And achieved good curative effect, but due to the distortion of the intracranial artery, the slender lumen, lack of support around it, and the blood supply to important parts, it has the characteristics of high risk and high technical requirements. There are only a few high-level hospitals in the world. This technology was launched.
China's first special intracranial stent successfully came out
Professor Jiang Weijian served as the head of the National "Tenth Five-Year" Science and Technology Research Project "Symptomic Intracranial Artery Stenosis Stenting Study", and cooperated with Minimally Invasive Medical Devices (Shanghai) Co., Ltd. for stenting of intracranial artery stenosis. Lack of special stents, as the first patent designer to develop and produce the first Apollo stent for the treatment of cerebral artery stenosis in China - "Apollo stent", successfully passed the clinical trial, and obtained the national food and drug supervision and management The Bureau's permission to "localize" the invention patent has ended the history of dependence on imports of cerebrovascular interventional stents, filled the domestic technical gap in this field, and also established China's international leading position in the field of intracranial vascular stenting. status. In October 2004, the "First International Conference on Intracranial Atherosclerosis" was held in Hong Kong. Internationally renowned neurologist and Professor Louis Caplan of Harvard University in the United States commented: "Chinese research on stenting of intracranial artery stenosis The aspect is at the international leading level."
With the special support, Professor Jiang Weijian led the first successful intracerebral artery balloon stent, Apollo stent and self-expanding stent surgery in China; as the project leader, Professor Jiang Weijian presided over the national “based on the dark zone image information. More than 10 major scientific research topics such as the treatment and evaluation of ischemic stroke and recanalization, more than 100 academic papers and monographs on "intravascular treatment of ischemic cerebrovascular disease", more than 10 articles including European and American authoritative magazines, becoming domestic Foreign professional textbooks. More than 20 achievements were awarded the first and second prizes of the national, military and Beijing scientific and technological progress achievements.
China's first intracranial special stent triggered high attention from foreign media
Professor Jiang Weijian not only developed the first intracranial special stent in China, but he also took this as a great opportunity to take the lead in internationally presenting the first angiographic classification for intracranial cerebral artery stenting; establishing the first standard in China. The database of intracranial interventional therapy. More than a thousand patients with symptomatic intracranial artery stenosis were treated with intracranial cerebral artery stent. The success rate was 97.6%, and the complication was the lowest in the world. The safety and effectiveness of intracranial stenting were confirmed. Related papers have been published in international authoritative journals such as the Journal of Neurology, Stroke, Cerebrovascular Disease, Journal of Radiology, American Journal of Neuroradiology, and Neurology Research. The American Stroke Association and the American Neurology Association held an official press conference for the results of the Jiang Weijian research team. International media such as the Washington Post, Reuters, Science News, and other media have also reported positively on their findings. This indicates that China's interventional treatment for stroke has reached the international leading level, and humans have taken an exploratory step in the prevention and treatment of stroke.
In 2007, the American Heart Association and the American Stroke Association held an international stroke conference in San Francisco, USA. Among the more than 4,000 participants, the association held an official media conference for only nine researchers. As the only Chinese expert, Jiang Weijian was invited to participate in the conference and answered questions that journalists were interested in. The British "Reuters" reported the results of the Jiang Weijian team with the title "The stent is used to open the narrow intracranial artery is safe and feasible." The US "Washington Post" did "a study from China showing that patients with prone to stroke due to stenosis of the brain may benefit from stenting at the stenosis." It made China's first intracranial special stent out of the country and raised the national prestige, causing a sensation in the international medical community.
American specialist in stunned intracranial artery stenting
With China's own intracranial special stent, Professor Jiang Weijian took the lead in establishing a new preoperative multi-modal clinical imaging evaluation system for intracerebral artery stenosis at home and abroad. Perioperative hypertension, blood glucose and lipid enhancement management and prevention and treatment of internal medicine The platform and a series of key technologies for personalized surgery have overcome the worldwide problem of high risk of brain stent surgery that has not been solved in Europe and the United States. Organized 20,000 operations to create the world's highest success rate and lowest complication record; and Cleveland Medicine The center cooperated to establish a multi-disciplinary bilateral agreement on cerebrovascular disease between China and the United States; cooperated with American Stryker to create the first international intracranial artery stent surgery training center; developed the first cerebrovascular occlusion recanal device to improve acute The prognosis of patients with ischemic stroke opens a new path. Once again on the international medical arena.
On October 15, 2013, Professor Jiang Weijian presided over the 5th New Era International Cerebrovascular Multidisciplinary Sharing Sino-US Bilateral Conference. More than 30 American experts came to the integrated cerebral vascular complex operating room of the Rocket General Hospital to observe the implementation of Professor Jiang Weijian. Intracranial artery stenting surgery. These experts, who are accustomed to the arbitrariness, suddenly rounded out their blue eyes and exclaimed: "There is no such high-end neurological intervention in the United States. I did not expect to see it in the Chinese military hospital. The missiles of your strategic missile units are powerful, and medical technology is also So amazing!" After that, Jiang Weijian was hired as the international editorial board of the American Journal of Neurological Interventional Surgery.
At the end of 2007, the American Stroke Association selected the top ten industry news. After the association recommended, Professor Jiang Weijian's Apollo stent intervention was successfully selected. The Washington Post and Reuters media interviewed Professor Jiang Weijian from abroad.
Jiang Weijian Introduction
Jiang Weijian, deputy dean of the Rocket General Hospital, director of the National Stroke Medical Treatment Research Center, chief physician, professor, doctoral tutor. An internationally renowned neurointervention expert, a pioneer and leader in the field of interventional diagnosis and treatment of ischemic cerebrovascular disease in China.
Member of the National Intervention Committee of the National Health and Family Planning Commission, Vice President of the Interventional Physician Branch of the Chinese Medical Association, Member of the Standing Committee of the Radiology Branch of the Chinese Medical Association and Chairman of the Interventional Committee, and Adjunct Professor of the Cleveland Medical Center, the top hospital in the United States Member of the editorial board of the American Journal of Neurological Interventional Surgery.
Jiang Weijian was engaged in interventional therapy for 40 years and created the first multi-disciplinary team of cerebrovascular diseases in China. In 2011, he was enlisted in the special campaign to create the first cerebrovascular disease complex operating room in China, forming a first-class intracranial level at home and abroad. Three technical features of arterial stenosis stenting, acute stroke comprehensive diagnosis and treatment and refractory cerebrovascular disease intervention and surgical combined surgery, the first in the country to carry out complex aneurysms, vascular malformations, vascular tumors and chronic carotid occlusion A number of innovative technologies for compound surgery.
Jiang Weijian has published more than 100 papers in several core journals in China, including more than 30 SCI papers, with a total impact factor of more than 200 points. Many research results have been recognized by international peers.
As the first leader, he has won 1 national key basic research and development plan, 1 national science and technology research project, 4 national natural fund, 1 first prize of scientific and technological progress by the Ministry of Education, and 1st medical achievement of the whole army. 1 award, 1st prize of Beijing Science and Technology Progress Award, 1st prize of China Medical Science and Technology Award, 1st prize of young and middle-aged experts with outstanding contributions from the Ministry of Health, 1 outstanding military science and technology talent award, 2nd grade 1 Times.
Special needs clinic time: Tuesday, Thursday afternoon
Source: China Military Network
Flood Barrier,Flood Door Barrier,Flood Control Barrier,Flood Stop Barrier
Denilco Environmental technology(Suzhou)Co., Ltd. , https://www.wflood.com